UK markets close in 2 hours 44 minutes

Virpax Pharmaceuticals, Inc. (VRPX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.3000-0.0100 (-0.43%)
At close: 04:00PM EST
2.3000 0.00 (0.00%)
Pre-market: 08:25AM EST
Full screen
Loading interactive chart…
  • Business Wire

    Altasciences Chosen by Virpax Pharmaceuticals, Inc. to Conduct First-in-Human Study of Epoladerm™ for Chronic Pain Associated with Osteoarthritis of the Knee

    LAVAL, Quebec, January 21, 2022--Altasciences is pleased to have been chosen by Virpax® Pharmaceuticals, Inc. ("Virpax") (NASDAQ:VRPX) to conduct a first-in-human study of Epoladerm™ (diclofenac epolamine) for chronic pain associated with osteoarthritis of the knee. This treatment is supplied in a pre-filled device for administration as a topical spray film.

  • Business Wire

    Virpax® Successfully Completes Preclinical Dermal Safety Studies for Epoladerm™

    BERWYN, Pa., January 18, 2022--Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders, and anti-viral indications, reported positive results of four preclinical dermal safety studies for Epoladerm™ (diclofenac epolamine). Epoladerm is an investigational product candidate for the management of pain associated with osteoarthritis of the knee. From these recently concluded animal studies, r

  • Business Wire

    Virpax® Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference

    BERWYN, Pa., January 04, 2022--Virpax® Pharmaceuticals, Inc. ("Virpax"), a company specializing in product candidates for pain management, CNS disorders and anti-viral indications, today announced that it will be presenting virtually at the upcoming H.C. Wainwright event from Monday, January 10th through Thursday, January 13th starting at 7:00 a.m. ET. Anthony Mack, Chairman & CEO of Virpax, will be giving the presentation. Management will also be hosting virtual one-on-one meetings on Monday, J